Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by bleedformeon Dec 21, 2009 1:55pm
412 Views
Post# 16607810

RE: RE: RE: RE: Pfizer buys stem-cell therapy from

RE: RE: RE: RE: Pfizer buys stem-cell therapy fromYou pump away.
If you believe in a company no one has the right to tell you to not extol what you consider it's virtues or point out similarities to other companies  in the field.  Obversely the same goes in pointing out a companies shortcomings. If you are privileged with information that may adversely affect a company or it's  stocks performance you should express your point of view.  
 All this talk about bashing a pumping amuses me the thought one person on one message board can affect the course of a company.
Bullboard Posts